The Valley Desk

NCT02960594 · Interventional trial

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Overall registry status Completed

Phase 1

Conditions Breast Cancer, ColoRectal Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, HepatoCellular Carcinoma, Lung Cancer, Ovarian Cancer, Pancreatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov